Kimberly-Clark Corp (KMB)

KMB (NYSE:Consumer Non-Durables) EQUITY
$134.63
pos +0.00
+0.00%
Today's Range: 133.57 - 134.65 | KMB Avg Daily Volume: 1,696,100
Last Update: 07/22/16 - 4:01 PM EDT
Volume: 0
YTD Performance: 5.76%
Open: $0.00
Previous Close: $133.36
52 Week Range: $103.04 - $138.87
Oustanding Shares: 360,127,819
Market Cap: 48,026,645,942
6-Month Chart
TheStreet Ratings Grade for KMB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 2
Moderate Buy 1 1 1 1
Hold 6 6 6 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.63 2.63 2.63 2.38
Latest Dividend: 0.92
Latest Dividend Yield: 2.76%
Dividend Ex-Date: 06/08/16
Price Earnings Ratio: 44.45
Price Earnings Comparisons:
KMB Sector Avg. S&P 500
44.45 44.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.11% 19.99% 37.83%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.70 -0.10 -0.04
Net Income -33.20 -0.40 -0.16
EPS -31.40 -0.40 -0.14
Earnings for KMB:
EBITDA 3.93B
Revenue 18.59B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.48 $1.56 $6.09 $6.53
Number of Analysts 5 3 7 6
High Estimate $1.51 $1.58 $6.15 $6.58
Low Estimate $1.46 $1.55 $6.04 $6.49
Prior Year $1.41 $1.51 $5.76 $6.09
Growth Rate (Year over Year) 5.11% 3.53% 5.70% 7.17%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 18, 2016 | 6:00 AM EDT
Let me give you the unassailable themes.
By

Chris Laudani

 | Jul 14, 2016 | 12:00 PM EDT
If KMB's 2Q report is as disappointing as 1Q, investors may seek a new safe haven.
By

Jim Cramer

 | Jul 11, 2016 | 2:29 PM EDT
All of these add up to a level of insecurity on the part of sidelined money.
By

Paul Price

 | Jun 21, 2016 | 8:00 AM EDT

Debt-fueled buybacks and an overly generous dividend are potential drags on the stock's value.

By

Jim Cramer

 | Jun 3, 2016 | 11:00 AM EDT
Investors should go shopping for blue-chip, dividend-paying stocks in the wake of the worse-than-expected May jobs report, says Jim Cramer.
By

Jim Cramer

 | May 23, 2016 | 1:07 PM EDT

U.S. companies with big overseas presence are getting hit.

By

Doug Kass

 | May 23, 2016 | 8:53 AM EDT
Sky-High Price-to-Earnings Ratios. Wall Street might historically view consumer staples as "defensive," but many have offensive valuations these days. Those have stemmed from an extended low-interest-rate period (which is likely to end shortly), coupled with the incorrect perception that consumer staples' profits will be immune to the soft global-economic backdrop. Yields That Won't Provide Adequate Support. Consumer staples' dividend yields no longer provide the safety net that many investors believe. As we saw with Campbell's, a good dividend yield provides little protection when fundamentals sour -- as they likely will for many firms in the more-competitive global backdrop that I expect. Inflation is rising, and with that will inevitably come higher interest rates, meaning that the sector's current yields will provide little support. Emerging-Market Profit Pressures. Don't view Campbell's as an outlier. Generic competition, a potentially strengthening U.S. dollar and higher input costs due to rising commodities prices all represent continuing profit threats for the sector. P/E/G Rates are Elevated. P/E/G rates -- or stock valuations relative to the potential for reduced or pressured secular profit growth -- serve as another significant headwind for consumer staples. In fact, the sector's P/E ratios are obscene in certain cases relative to expected five-year growth rates, as this chart shows: Company                              P/E*               Div. Yield         5-year Expected EPS Gain Campbell                              27.1               2.08%           &nb
By

Doug Kass

 | May 10, 2016 | 3:17 PM EDT
Markets were oversold. The S&P 500 held the 50-day moving average. The put/call ratio popped back up.  From here, the key might be to watch what other asset classes rally with e
By

Jim Cramer

 | May 4, 2016 | 11:00 AM EDT
Investors are going to rotate back into safety stocks if the April jobs number disappoints on Friday, says TheStreet's Jim Cramer.
By

Doug Kass

 | Apr 27, 2016 | 3:50 PM EDT
Inside day in the markets, at least as of 3 p.m. ET (in the time that it took to write "Takeaways," the S&P rose by seven handles). Ss (S&P) over Ns (Nasdaq). The U.S. dollar weakened after the Fed's comments. Crude oil advanced by $1.13 to $45.17. Gold rose by $4.60 to $1,248. Agricultural commodities gave back on price. Wheat -3.25, corn -3.25, soybean -3.00 and oats +2.50. Lumber +9.20. Bonds erupted higher in price, lower in yield after above. That is why I re-shorted Financial Select Sector SPDR ETF (XLF) at $23.73. The yield on the 10-year U.S. note dropped by an outsize seven basis points to 1.86% and the long bond by five basis points to 2.70%. Municipals were well-bid and closed-end municipal bond funds advanced ... again. Big mistake selling them earlier in the year on my part! The high-yield bond market moved higher. Blackstone/GSO Strategic Credit Fund (BGB) paused and was flat. Banks experienced some early strength, sold off on the Fed's comments and are beginning to rally from the lows. Brokerages were stronger. Life insurance was unchanged despite the rise in bond prices. Retail was stronger across the board. Former long Macy's (M) was up 45 cents and short Nordstrom (JWN) was up 55 cents. Energy stocks rallied with crude oil. Schlumberger (SLB) rose $1.63 and Exxon Mobil (XOM) was up $1.00. Some positive dividend moves within the space. Old tech was quiet, though IBM (IBM) was up $1.60. Biotech was down most of the day, but experiencing a late day rally. iShares Nasdaq Biotechnology ETF (IBB) was down $1.70. My biotech basket of speculative stocks still appears to be rolling over. Consumer non-durables thrived, as Kimberly-Clark (KMB) bounced from recent weakness and Procter & Gamble (PG) was up 55 cents. Short Coca-Cola (KO) was fractionally higher. Autos were dead flat. Ag equipment was higher, with Caterpillar (CAT) up $1.15 and Deere (DE) up $1.50. (T)FANG continues weak, led by AMZN, down $9, and Tesla (TSLA), down $2.60. Trade of the Week short iShares China Large-Cap ETF (FXI) continues to rally, up 30 cents. NOSH was mixed; Starbucks (SBUX), a favorite short, continues to decline, down 72 cents. It appears to be breaking down from the earnings report last week. Mine is a minority view. CRABBY was helped by Radian Group (RDN), which had an earnings beat and some good credit data (more to come later in the week). In miscellaneous names, Twitter (TWTR) was a twit and Potash (POT) rallied by 40 cents after Monsanto (MON) was upgraded yesterday. Apple was down between $6 and $7 most of the day. Here are some good columns from RealMoneyPro today: Jim "El Capitan" Cramer on the market, which is impervious to Apple.  Apple mea culpa (I respect his candidness) from Mark Sebastian.  Shad Gad "And the Pharoahs" on how to beat the pros.  James Passeri on Mr. Ackman Goes to Washington.  Jack and Jim on Twitter. 
Market staging nice rally to end the week.  Oil down and seems ~$45 a barrel has beco...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.